BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 21172787)

  • 41. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy of new antifungal agents.
    Kauffman CA
    Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive fungal infections: the challenge continues.
    Gullo A
    Drugs; 2009; 69 Suppl 1():65-73. PubMed ID: 19877737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Cecil JA; Wenzel RP
    Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drugs in Clinical Development for Fungal Infections.
    Gonzalez-Lara MF; Sifuentes-Osornio J; Ostrosky-Zeichner L
    Drugs; 2017 Sep; 77(14):1505-1518. PubMed ID: 28840541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current status and future of antifungal therapy for systemic mycoses.
    Nosanchuk JD
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):75-84. PubMed ID: 18221136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal therapeutics for dimorphic fungal pathogens.
    Goughenour KD; Rappleye CA
    Virulence; 2017 Feb; 8(2):211-221. PubMed ID: 27646561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Newer antifungal agents.
    Abuhammour W; Habte-Gaber E
    Indian J Pediatr; 2004 Mar; 71(3):253-9. PubMed ID: 15080413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.
    Azie N; Neofytos D; Pfaller M; Meier-Kriesche HU; Quan SP; Horn D
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):293-300. PubMed ID: 22789847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New antifungal antibiotics.
    Paiva JA; Pereira JM
    Curr Opin Infect Dis; 2013 Apr; 26(2):168-74. PubMed ID: 23411420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
    Kontoyiannis DP; Mantadakis E; Samonis G
    J Hosp Infect; 2003 Apr; 53(4):243-58. PubMed ID: 12660121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current challenges in the management of invasive fungal infections.
    Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
    J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uncommon yeast infections in hematological patients: from diagnosis to treatment.
    Caira M; Trecarichi EM; Tumbarello M; Leone G; Pagano L
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1067-75. PubMed ID: 22029524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine].
    Lichtenstern C; Swoboda S; Hirschburger M; Domann E; Hoppe-Tichy T; Winkler M; Lass-Flörl C; Weigand MA
    Anaesthesist; 2010 Jan; 59(1):30-52. PubMed ID: 20082061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal pharmacodynamics: Latin America's perspective.
    Gonzalez JM; Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
    Braz J Infect Dis; 2017; 21(1):79-87. PubMed ID: 27821250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.
    Pana ZD; Kougia V; Roilides E
    Expert Opin Pharmacother; 2015 Apr; 16(5):693-710. PubMed ID: 25676454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antifungal agents in neonates: issues and recommendations.
    Almirante B; Rodríguez D
    Paediatr Drugs; 2007; 9(5):311-21. PubMed ID: 17927303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elucidating drug resistance in human fungal pathogens.
    Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
    Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.